Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7331 p12
1/8 January 2005

This article
Reprint   Photocopy

PDF 85K, Acrobat Reader

Letters

· Drug donations
· CAM
· Pharmacy in Scotland
· Community pharmacy
· Prescribing
· Prosecution
· New contract (2)
· CPD
· Registration exam (2)
· Barcodes
· Retention fee (2)
· New Year's resolutions
· The Society
· The Journal (2)


Letters to the Editor

Drug donations

Not a dumping ground

From Miss V. Parker, MRPharmS

Having just read the letters in The Journal of 9 October 2004, I would like to share my experiences of drug donations in a developing country. For the past 22 months I have worked as a VSO volunteer in a district hospital in Ifakara, Southern Tanzania. I have just spent the last week, together with five colleagues, sorting through almost 100 boxes of drug donations from Italy. Not only had the vast majority of these medicines already expired (many as long ago as September 2003), many were wholly inappropriate for use in our hospital. We also had to pay for their storage and transport from Dar es Salaam.

Among the items I consider inappropriate were camouflage cream (for white skin), statins (we do not have the facilities to measure cholesterol), over 100 bottles of St John’s wort, two crates of epoprostenol infusion, 100 boxes of shampoo sachets and wet wipes (inside boxes labelled as containing Valsartan capsules). Drugs which could be used are rendered less useful by the fact that we receive free samples. Often such boxes contain seven or more blisters but not all of the blisters contain tablets. One must therefore open every box and play a guessing game to find out which blisters contain a tablet and which ones air. We have had numerous occasions when patients have returned with blister packs to say there was only one dose present when we believed the pack to be full. This increases not only our transport costs (due to the large number of boxes) but also our workload by having to inspect every strip individually.

On top of all this we receive no English translations, which often causes us huge problems.

I was pleased to read about Intercare. It is through companies such as these that donations should be made. If donations are to be sent, donors should consider what they are sending, the disease pattern at the medicine’s destination and the quantities sent. We may be poorer than the Western world, but we are not a dumping ground for unwanted free samples.

Victoria Parker
Ifakara, Tanzania

Send your letter to The Editor

Next Topic (CAM)

Back to Top


©The Pharmaceutical Journal